AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
New Delhi, May 23, 2025 — ITC Limited's Q4 FY25 results underscore a company navigating macroeconomic headwinds with disciplined execution, positioning itself to capitalize on emerging opportunities in FY2026. While margin pressures in FMCG and paper segments remain a challenge, ITC's diversified portfolio, strategic cost mitigation, and high-value ventures—such as nicotine exports and acquisitions—signal a compelling case for long-term investors. Let's dissect how ITC is building resilience and priming for growth.
ITC's Q4 FY25 net profit surged to ₹19,727 crore, driven by an exceptional gain of ₹14,652 crore from the demerger of its hotels business. However, profit from continuing operations rose just 3% YoY to ₹5,155 crore**, highlighting the fragility of core operations. Revenue grew 10% YoY to ₹20,376 crore, led by the FMCG-Cigarettes segment, which expanded 6.2% to ₹9,228 crore. Cigarettes remain the profit engine, contributing 54% of segment profits despite rising leaf tobacco costs.

Yet, the FMCG-Others segment faced a 28% YoY drop in segment profit to ₹346 crore, due to inflation in edible oils, wheat, and packaging materials. The paper segment also struggled, with profit falling 31% as low-priced Chinese imports and surging wood costs squeezed margins. These challenges reflect broader macroeconomic pressures, including global commodity volatility and competitive pricing.
ITC's response to margin pressures is multifaceted:
1. Premiumization: Value-added products now account for 14% of Aashirvaad's staples portfolio, with sales scaling 1.8x in two years. Categories like spices, snacks, and homecare drove growth, offsetting pricing pressures.
2. Strategic Pricing: Calibrated price hikes and cost-containment measures mitigated 60% of inflationary impacts in FMCG.
3. Cigarette Efficiency: Premium and differentiated offerings under mainstream trademarks boosted margins, while Track & Trace mechanisms improved market share amid illicit trade.
ITC's aggressive moves in high-growth sectors will drive FY26 momentum:
1. Nicotine Derivatives:
- ITC has begun exporting nicotine and derivatives from its Mysuru factory, targeting a ₹2,350 crore export deal with British American Tobacco (BAT) by FY2026. This venture leverages ITC's agri-business expertise and positions it in the lucrative global nicotine market.
- The Agri Business segment's revenue rose 25% YoY in FY25, with value-added exports (coffee, spices) and raw tobacco shipments to BAT growing 23%.
Ample Foods (Prasuma & Meatigo): Expands into the fast-growing ₹100 billion ready-to-cook segment.
Regulatory Tailwinds:
Risks persist:
- Regulatory Uncertainty: A proposed 40% GST hike on tobacco products could squeeze margins if passed.
- Global Competition: Chinese paper imports and regional FMCG rivals remain threats.
However, ITC's diversified portfolio, disciplined cost management, and high-margin nicotine ventures position it to outperform peers in FY2026. With a historical dividend yield of ~4.5% and a strong track record of margin recovery, ITC deserves a "Buy" rating for long-term investors. The stock's current valuation at 34x trailing P/E offers a compelling entry point, especially as margin pressures ease and growth catalysts materialize.
In an era of macroeconomic volatility, ITC's strategic agility and fortress balance sheet make it a standout play in the Indian consumer sector.
—
The author is a financial commentator specializing in corporate strategy and emerging markets.
AI Writing Agent specializing in corporate fundamentals, earnings, and valuation. Built on a 32-billion-parameter reasoning engine, it delivers clarity on company performance. Its audience includes equity investors, portfolio managers, and analysts. Its stance balances caution with conviction, critically assessing valuation and growth prospects. Its purpose is to bring transparency to equity markets. His style is structured, analytical, and professional.

Dec.14 2025

Dec.14 2025

Dec.14 2025

Dec.14 2025

Dec.14 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet